• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肥大性骨关节病中的皮肤纤维蛋白溶解活性。

Cutaneous fibrinolytic activity in primary hypertrophic osteoarthropathy.

作者信息

Matucci-Cerinic M, Lotti T, Jajic I, Di Lollo S, Brunetti L, Orlic D

出版信息

Scand J Rheumatol. 1987;16(3):205-12. doi: 10.3109/03009748709165275.

DOI:10.3109/03009748709165275
PMID:3602953
Abstract

Cutaneous fibrinolytic activity was investigated in 13 patients affected with Primary Hypertrophic Osteoarthropathy in the advanced phase. Biopsies were taken from periungueal skin of the ippocratic finger and from the dorsum of the first phalanx: cutaneous fibrinolytic activity was investigated with Todd's autohistographic method as modified by Lotti et al., showing increased activity in periungueal skin (10/13) and normal in the apparently uninvolved skin (9/13). We suggest that the increase in plasminogen activator activity, in the advanced phase of the disease, may be related to the increased growth of the connective tissue that is characteristic of the disease.

摘要

对13例处于晚期的原发性肥厚性骨关节病患者的皮肤纤溶活性进行了研究。从希波克拉底面(译者注:此处ippocratic finger可能有误,疑似hippocratic finger,希波克拉底面,即杵状指周围皮肤)的甲周皮肤和第一指骨背侧取活检组织:采用洛蒂等人改良的托德自动组织学方法研究皮肤纤溶活性,结果显示甲周皮肤活性增加(10/13),而在明显未受累的皮肤中活性正常(9/13)。我们认为,在疾病晚期纤溶酶原激活物活性增加可能与该病特有的结缔组织过度生长有关。

相似文献

1
Cutaneous fibrinolytic activity in primary hypertrophic osteoarthropathy.原发性肥大性骨关节病中的皮肤纤维蛋白溶解活性。
Scand J Rheumatol. 1987;16(3):205-12. doi: 10.3109/03009748709165275.
2
The role of plasminogen activators in alopecia areata.纤溶酶原激活剂在斑秃中的作用。
Int J Dermatol. 1991 Jan;30(1):19-21. doi: 10.1111/j.1365-4362.1991.tb05873.x.
3
Pachydermoperiostosis (primary hypertrophic osteoarthropathy): in vitro evidence for abnormal fibroblast proliferation.
Clin Exp Rheumatol. 1992 May-Jun;10 Suppl 7:57-60.
4
[Pachydermoperiostosis (primary hypertrophic osteoarthropathy)].[厚皮性骨膜病(原发性肥大性骨关节病)]
Medicina (B Aires). 2006;66(2):147-9.
5
Cutaneous fibrinolytic activity in scleroderma.
Clin Exp Rheumatol. 1985 Jul-Sep;3(3):249-53.
6
Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation.
Int J Dermatol. 1990 Nov;29(9):644-8. doi: 10.1111/j.1365-4362.1990.tb02587.x.
7
Fibrinolytic activity in the synovial membrane of osteoarthritis.骨关节炎滑膜中的纤溶活性。
Br J Rheumatol. 1990 Aug;29(4):249-53. doi: 10.1093/rheumatology/29.4.249.
8
Increased collagen synthesis in skin fibroblasts from patients with primary hypertrophic osteoarthropathy. Evidence for trans-activational regulation of collagen transcription.
Arthritis Rheum. 1994 Sep;37(9):1386-94. doi: 10.1002/art.1780370918.
9
Mesoglycan treatment restores defective fibrinolytic potential in cutaneous necrotizing venulitis.硫酸乙酰肝素治疗可恢复皮肤坏死性静脉炎中缺陷的纤溶潜能。
Int J Dermatol. 1993 May;32(5):368-71. doi: 10.1111/j.1365-4362.1993.tb01477.x.
10
A case of primary hypertrophic osteoarthropathy without skin involvement (Currarino's disease).
Rev Rhum Engl Ed. 1998 Oct;65(10):591-3.

引用本文的文献

1
Hypertrophic osteoarthropathy: endothelium and platelet function.肥厚性骨关节病:内皮与血小板功能
Clin Rheumatol. 1996 Sep;15(5):435-9. doi: 10.1007/BF02229639.
2
Colchicine treatment in a case of pachydermoperiostosis with acroosteolysis.秋水仙碱治疗一例伴有肢端骨质溶解的厚皮性骨膜病。
Rheumatol Int. 1988;8(4):185-8. doi: 10.1007/BF00270458.
3
Pachydermoperiostosis (primary hypertrophic osteoarthropathy): report of a case with evidence of endothelial and connective tissue involvement.厚皮性骨膜病(原发性肥大性骨关节病):1例内皮及结缔组织受累的病例报告
Ann Rheum Dis. 1989 Mar;48(3):240-6. doi: 10.1136/ard.48.3.240.
4
Bone abnormalities and severe arthritis in pachydermoperiostosis.厚皮性骨膜病中的骨骼异常与严重关节炎。
Ann Rheum Dis. 1992 Mar;51(3):416-9. doi: 10.1136/ard.51.3.416.